- Home
- ORGO vs ZIMV Comparison
ORGO vs ZIMV Comparison
Compare ORGO & ZIMV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- ZIMV
- Stock Information
- Founded
- ORGO 1985
- ZIMV 2021
- Country
- ORGO United States
- ZIMV United States
- Employees
- ORGO N/A
- ZIMV N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ORGO Health Care
- ZIMV Health Care
- Exchange
- ORGO Nasdaq
- ZIMV Nasdaq
- Market Cap
- ORGO 620.3M
- ZIMV 532.4M
- IPO Year
- ORGO N/A
- ZIMV N/A
- Fundamental
- Price
- ORGO $4.90
- ZIMV $18.88
- Analyst Decision
- ORGO Buy
- ZIMV Hold
- Analyst Count
- ORGO 2
- ZIMV 3
- Target Price
- ORGO $7.50
- ZIMV $14.50
- AVG Volume (30 Days)
- ORGO 761.1K
- ZIMV 666.4K
- Earning Date
- ORGO 11-11-2025
- ZIMV 10-29-2025
- Dividend Yield
- ORGO N/A
- ZIMV N/A
- EPS Growth
- ORGO N/A
- ZIMV N/A
- EPS
- ORGO N/A
- ZIMV N/A
- Revenue
- ORGO $429,531,000.00
- ZIMV $443,402,000.00
- Revenue This Year
- ORGO $2.57
- ZIMV $2.49
- Revenue Next Year
- ORGO $9.80
- ZIMV $1.26
- P/E Ratio
- ORGO N/A
- ZIMV N/A
- Revenue Growth
- ORGO N/A
- ZIMV N/A
- 52 Week Low
- ORGO $2.48
- ZIMV $8.15
- 52 Week High
- ORGO $6.71
- ZIMV $19.01
- Technical
- Relative Strength Index (RSI)
- ORGO 52.77
- ZIMV 75.30
- Support Level
- ORGO $4.75
- ZIMV $18.85
- Resistance Level
- ORGO $5.10
- ZIMV $18.93
- Average True Range (ATR)
- ORGO 0.21
- ZIMV 0.06
- MACD
- ORGO -0.02
- ZIMV -0.19
- Stochastic Oscillator
- ORGO 39.39
- ZIMV 29.41
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.